March 20, 2018 8:54 AM ET

Healthcare Providers and Services

Company Overview of Takara Bio USA Inc.

Company Overview

Takara Bio USA, Inc. distributes pharmaceutical products. It offers PCR and protein research products, as well as various products in the areas of molecular biology, cell biology, and glycobiology. The company was founded in 2004 and is based in Madison, Wisconsin. As of March 29, 2007, Takara Bio USA, Inc. is a subsidiary of Takara Bio, Inc.

510 Charmany Drive

Madison, WI 53719

United States

Founded in 2004





Key Executives for Takara Bio USA Inc.

Takara Bio USA Inc. does not have any Key Executives recorded.

Takara Bio USA Inc. Key Developments

Takara Bio Unveils SMART-Ssq® Technology for Sensitive Full-Length Transcriptome Analysis at AGBT 2018

Takara Bio USA Inc. announced the launch of the SMARTer™ ICELL8® cx System. The system will be presented to the scientific community at the Advances in Genome Biology and Technology (AGBT) General Meeting in Orlando FL, February 12–15, 2018. This new open-platform, high-throughput single-cell automation system allows researchers to gain greater confidence in the results of their single-cell analyses by using innovative technologies that allow only the most informative cells to be processed and analyzed. While the system will come prevalidated with several SMARTer® applications, it will also provide the flexibility to enable users to develop applications of their choice. The SMARTer ICELL8 cx System includes a built-in imaging station and software analysis tool to visualize individual nanowells and process the images to differentiate single cells from empty wells or wells containing multiple cells. The multicolor imaging capability also provides the opportunity to perform applications like live-dead differentiation using suitable dyes. The unique imaging component differentiates this platform from other high-throughput platforms by generating cleaner data and eliminating background noise thus increasing confidence in the data obtained. TBUSA also announced the availability of its SMART-Seq full-length transcriptome analysis technology on the SMARTer ICELL8 system. High-throughput single-cell RNA-seq has seen many advancements involving automation processes in recent years. Most of these high-throughput automation methods, however, have been limited by only allowing differential expression (DE) with end-capture methods such as 3' DE or 5' DE.

Takara Bio USA Inc. Announces Unaudited Earnings Results for the Nine Months Ended December 31, 2017

Takara Bio USA Inc. announced unaudited earnings results for the nine months ended December 31, 2017. For the nine months, the company announced net sales of JPY 7,513 million compared to JPY 6,286 million a year ago. Operating income was JPY 523 million compared to JPY 1,511 million a year ago.

Takara Bio USA Inc. Reports Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Full Year Ending March 31, 2018

Takara Bio USA Inc. reported earnings results for the six months ended September 30, 2017. For the six months, the company's net sales were JPY 5,018 million against JPY 4,450 million last year. Operating income was JPY 327 million against JPY 1,124 million last year. The company provided earnings guidance for the full year ending March 31, 2018. For the year, the company expects net sales of JPY 10,853 million and operating income of JPY 1,154 million.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Takara Bio USA Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at